The Rozy View: US Medtechs Face New Reg Burdens On Entering EU Market
Executive Summary
The EU MDR and IVDR have finally been adopted, which is good news in the sense that regulatory certainty is guaranteed, but bad news in terms of the extra compliance costs that industry, including US medtechs, will have to face in the coming years.